• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

TWO CASE OF ATYPICAL ENDOMETRIAL HYPERPLASIA ASSOCIATED WITH "BIOIDENTICAL" HORMONE REPLACEMENT THERAPY: IGCS-0084 Uterine Cancer, including Sarcoma.

作者信息

Dezman Vrabic L, Gersak M Z, Gersak K

机构信息

1Gynecology, Health Center Kranj, Kranj, Slovenia 2University of Ljubljana, School of Medicine, Ljubljana, Slovenia 3Department of Obstetrics and Gynecology University Medical Center Ljubljana, School of Medicine University of Ljubljana, Ljubljana, Slovenia.

出版信息

Int J Gynecol Cancer. 2015 May;25 Suppl 1:71. doi: 10.1097/00009577-201505001-00056.

DOI:10.1097/00009577-201505001-00056
PMID:25955947
Abstract
摘要

相似文献

1
TWO CASE OF ATYPICAL ENDOMETRIAL HYPERPLASIA ASSOCIATED WITH "BIOIDENTICAL" HORMONE REPLACEMENT THERAPY: IGCS-0084 Uterine Cancer, including Sarcoma.两例与“生物同源性”激素替代疗法相关的非典型子宫内膜增生：IGCS - 0084子宫癌，包括肉瘤。
Int J Gynecol Cancer. 2015 May;25 Suppl 1:71. doi: 10.1097/00009577-201505001-00056.
2
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory.绝经后女性获取生物同源激素替代疗法的途径：一项探索性研究。
Int J Pharm Compd. 2010 Mar-Apr;14(2):165-9.
3
Efficacy and tolerability of compounded bioidentical hormone replacement therapy.复方生物等效激素替代疗法的疗效和耐受性
Int J Pharm Compd. 2004 Jul-Aug;8(4):313-9.
4
The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.舌下含服与局部应用复方生物同源激素替代疗法对绝经后女性的有效性：一项观察性队列研究
Int J Pharm Compd. 2014 Jan-Feb;18(1):70-7.
5
THE SIGNIFICANCE OF PRE-OPERATIVE ENDOMETRIAL SAMPLING IN GRADE 1, LOW RISK ENDOMETRIAL CANCERS: IGCS-0088 Uterine Cancer, including Sarcoma.术前子宫内膜取样在1级低风险子宫内膜癌中的意义：IGCS - 0088子宫癌，包括肉瘤
Int J Gynecol Cancer. 2015 May;25 Suppl 1:72-3. doi: 10.1097/00009577-201505001-00057.
6
Bioidentical hormone therapy in menopause: relevance in dermatology.更年期的生物同源激素疗法：在皮肤科的相关性
Dermatol Online J. 2019 Jan 15;25(1):13030/qt4c20m28z.
7
EARLY STAGE ENDOMETRIAL CANCER: LAPAROSCOPY VS LAPAROTOMY: IGCS-0081 Uterine Cancer, including Sarcoma.早期子宫内膜癌：腹腔镜检查与剖腹手术：IGCS - 0081子宫癌，包括肉瘤
Int J Gynecol Cancer. 2015 May;25 Suppl 1:70. doi: 10.1097/00009577-201505001-00055.
8
UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR: IGCS-0060 Uterine Cancer, including Sarcoma.未分化子宫内膜癌，一种具有侵袭性的不同实体：IGCS - 0060子宫癌，包括肉瘤。
Int J Gynecol Cancer. 2015 May;25 Suppl 1:69. doi: 10.1097/00009577-201505001-00054.
9
Endometrial proliferative lesions associated with uterine fibromatosis.
Rom J Morphol Embryol. 2012;53(3 Suppl):743-7.
10
The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.复合生物等效透皮激素疗法对围绝经期和绝经后女性的止血、炎症、免疫因子、心血管生物标志物、生活质量指标及健康结局的影响。
Int J Pharm Compd. 2013 Jan-Feb;17(1):74-85.

引用本文的文献

1
Determination of estradiol and progesterone content in capsules and creams from compounding pharmacies.测定复方药剂房中胶囊和乳膏中的雌二醇和孕酮含量。
Menopause. 2019 Sep;26(9):966-971. doi: 10.1097/GME.0000000000001356.
2
Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms.评估雌孕激素口服胶囊（TX-001HR）治疗中重度血管舒缩症状的临床意义。
Menopause. 2019 May;26(5):513-519. doi: 10.1097/GME.0000000000001261.
3
Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
口服 17β-雌二醇/孕激素（TX-001HR）治疗绝经后血管舒缩症状对生活质量的影响。
Menopause. 2019 May;26(5):506-512. doi: 10.1097/GME.0000000000001271.
4
Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors.女性健康倡议后子宫内膜癌发病率增加：危险因素评估。
J Womens Health (Larchmt). 2019 Feb;28(2):237-243. doi: 10.1089/jwh.2018.6956. Epub 2018 Nov 28.